 | • レポートコード：B-GIR09D2840 • 出版社/出版日：GlobalInfoResearch / 2019年9月11日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、135ページ • 納品方法：Eメール • 産業分類：医薬品・ヘルスケア |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、紫斑療法薬の世界市場について調べ、まとめました。種類別セグメントは、アレルギー性紫斑病、血小板減少性紫斑病等、用途別セグメントは、病院利用、診療所利用、家庭、その他等に区分しました。紫斑療法薬の世界市場概観、メーカー動向、メーカー別紫斑療法薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・紫斑療法薬の市場概観 ・紫斑療法薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・紫斑療法薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・紫斑療法薬の世界市場規模 ・紫斑療法薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・紫斑療法薬のアメリカ市場規模推移 ・紫斑療法薬のカナダ市場規模推移 ・紫斑療法薬のメキシコ市場規模推移 ・紫斑療法薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・紫斑療法薬のドイツ市場規模推移 ・紫斑療法薬のイギリス市場規模推移 ・紫斑療法薬のロシア市場規模推移 ・紫斑療法薬のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・紫斑療法薬の日本市場規模推移 ・紫斑療法薬の中国市場規模推移 ・紫斑療法薬の韓国市場規模推移 ・紫斑療法薬のインド市場規模推移 ・紫斑療法薬の東南アジア市場規模推移 ・紫斑療法薬の南米市場分析（ブラジル、アルゼンチン等） ・紫斑療法薬の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・紫斑療法薬の種類別分析/販売量、売上、市場シェア（アレルギー性紫斑病、血小板減少性紫斑病） ・紫斑療法薬の用途別分析/市場規模（病院利用、診療所利用、家庭、その他） ・紫斑療法薬の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・紫斑療法薬の販売チャネル・代理店・貿易業者・ディーラー分析 |
Purpura is one of the common hemorrhagic diseases in children, which is characterized by blood spillage under skin and mucous membrane, petechiae and pressure stasis
Scope of the Report:
The worldwide market for Purpura Therapy Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Purpura Therapy Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Bristol-Myers Squibb Company
Pfizer Inc
GlaxoSmithKline Plc
Novartis AG
Hovione
Sanofi Winthrop Industrie S.A.
Hoffman-L Roche
Amgen Inc
Grifols Biologicals Inc
Ablynx NV
Biogen Inc
KM Biologics
Lee’s Pharmaceutical Holdings Ltd
Omeros Corp
Shire Plc
Roch
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Allergic Purpura
Thrombocytopenic Purpura
Market Segment by Applications, can be divided into
Hospital Use
Clinic Use
Household
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Purpura Therapy Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Purpura Therapy Drugs, with price, sales, revenue and global market share of Purpura Therapy Drugs in 2017 and 2018.
Chapter 3, the Purpura Therapy Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Purpura Therapy Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Purpura Therapy Drugs market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Purpura Therapy Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Purpura Therapy Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Allergic Purpura
1.2.2 Thrombocytopenic Purpura
1.3 Market Analysis by Applications
1.3.1 Hospital Use
1.3.2 Clinic Use
1.3.3 Household
1.3.4 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Bristol-Myers Squibb Company
2.1.1 Business Overview
2.1.2 Purpura Therapy Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Bristol-Myers Squibb Company Purpura Therapy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Pfizer Inc
2.2.1 Business Overview
2.2.2 Purpura Therapy Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Pfizer Inc Purpura Therapy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 GlaxoSmithKline Plc
2.3.1 Business Overview
2.3.2 Purpura Therapy Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 GlaxoSmithKline Plc Purpura Therapy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Novartis AG
2.4.1 Business Overview
2.4.2 Purpura Therapy Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Novartis AG Purpura Therapy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Hovione
2.5.1 Business Overview
2.5.2 Purpura Therapy Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Hovione Purpura Therapy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Sanofi Winthrop Industrie S.A.
2.6.1 Business Overview
2.6.2 Purpura Therapy Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Sanofi Winthrop Industrie S.A. Purpura Therapy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Hoffman-L Roche
2.7.1 Business Overview
2.7.2 Purpura Therapy Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Hoffman-L Roche Purpura Therapy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 Amgen Inc
2.8.1 Business Overview
2.8.2 Purpura Therapy Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Amgen Inc Purpura Therapy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 Grifols Biologicals Inc
2.9.1 Business Overview
2.9.2 Purpura Therapy Drugs Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Grifols Biologicals Inc Purpura Therapy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 Ablynx NV
2.10.1 Business Overview
2.10.2 Purpura Therapy Drugs Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Ablynx NV Purpura Therapy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.11 Biogen Inc
2.11.1 Business Overview
2.11.2 Purpura Therapy Drugs Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Biogen Inc Purpura Therapy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.12 KM Biologics
2.12.1 Business Overview
2.12.2 Purpura Therapy Drugs Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 KM Biologics Purpura Therapy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.13 Lee’s Pharmaceutical Holdings Ltd
2.13.1 Business Overview
2.13.2 Purpura Therapy Drugs Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Lee’s Pharmaceutical Holdings Ltd Purpura Therapy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.14 Omeros Corp
2.14.1 Business Overview
2.14.2 Purpura Therapy Drugs Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Omeros Corp Purpura Therapy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.15 Shire Plc
2.15.1 Business Overview
2.15.2 Purpura Therapy Drugs Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Shire Plc Purpura Therapy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.16 Roch
2.16.1 Business Overview
2.16.2 Purpura Therapy Drugs Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Roch Purpura Therapy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Purpura Therapy Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Purpura Therapy Drugs Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Purpura Therapy Drugs Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Purpura Therapy Drugs Manufacturer Market Share in 2018
3.3.2 Top 6 Purpura Therapy Drugs Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Purpura Therapy Drugs Market Analysis by Regions
4.1 Global Purpura Therapy Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Purpura Therapy Drugs Sales and Market Share by Regions (2014-2019)
4.1.2 Global Purpura Therapy Drugs Revenue and Market Share by Regions (2014-2019)
4.2 North America Purpura Therapy Drugs Sales and Growth Rate (2014-2019)
4.3 Europe Purpura Therapy Drugs Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Purpura Therapy Drugs Sales and Growth Rate (2014-2019)
4.5 South America Purpura Therapy Drugs Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Purpura Therapy Drugs Sales and Growth Rate (2014-2019)
5 North America Purpura Therapy Drugs by Country
5.1 North America Purpura Therapy Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Purpura Therapy Drugs Sales and Market Share by Country (2014-2019)
5.1.2 North America Purpura Therapy Drugs Revenue and Market Share by Country (2014-2019)
5.2 United States Purpura Therapy Drugs Sales and Growth Rate (2014-2019)
5.3 Canada Purpura Therapy Drugs Sales and Growth Rate (2014-2019)
5.4 Mexico Purpura Therapy Drugs Sales and Growth Rate (2014-2019)
6 Europe Purpura Therapy Drugs by Country
6.1 Europe Purpura Therapy Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Purpura Therapy Drugs Sales and Market Share by Country (2014-2019)
6.1.2 Europe Purpura Therapy Drugs Revenue and Market Share by Country (2014-2019)
6.2 Germany Purpura Therapy Drugs Sales and Growth Rate (2014-2019)
6.3 UK Purpura Therapy Drugs Sales and Growth Rate (2014-2019)
6.4 France Purpura Therapy Drugs Sales and Growth Rate (2014-2019)
6.5 Russia Purpura Therapy Drugs Sales and Growth Rate (2014-2019)
6.6 Italy Purpura Therapy Drugs Sales and Growth Rate (2014-2019)
7 Asia-Pacific Purpura Therapy Drugs by Country
7.1 Asia-Pacific Purpura Therapy Drugs Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Purpura Therapy Drugs Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Purpura Therapy Drugs Revenue and Market Share by Country (2014-2019)
7.2 China Purpura Therapy Drugs Sales and Growth Rate (2014-2019)
7.3 Japan Purpura Therapy Drugs Sales and Growth Rate (2014-2019)
7.4 Korea Purpura Therapy Drugs Sales and Growth Rate (2014-2019)
7.5 India Purpura Therapy Drugs Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Purpura Therapy Drugs Sales and Growth Rate (2014-2019)
8 South America Purpura Therapy Drugs by Country
8.1 South America Purpura Therapy Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Purpura Therapy Drugs Sales and Market Share by Country (2014-2019)
8.1.2 South America Purpura Therapy Drugs Revenue and Market Share by Country (2014-2019)
8.2 Brazil Purpura Therapy Drugs Sales and Growth Rate (2014-2019)
8.3 Argentina Purpura Therapy Drugs Sales and Growth Rate (2014-2019)
8.4 Colombia Purpura Therapy Drugs Sales and Growth Rate (2014-2019)
9 Middle East and Africa Purpura Therapy Drugs by Countries
9.1 Middle East and Africa Purpura Therapy Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Purpura Therapy Drugs Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Purpura Therapy Drugs Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Purpura Therapy Drugs Sales and Growth Rate (2014-2019)
9.3 Turkey Purpura Therapy Drugs Sales and Growth Rate (2014-2019)
9.4 Egypt Purpura Therapy Drugs Sales and Growth Rate (2014-2019)
9.5 Nigeria Purpura Therapy Drugs Sales and Growth Rate (2014-2019)
9.6 South Africa Purpura Therapy Drugs Sales and Growth Rate (2014-2019)
10 Global Purpura Therapy Drugs Market Segment by Type
10.1 Global Purpura Therapy Drugs Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Purpura Therapy Drugs Sales and Market Share by Type (2014-2019)
10.1.2 Global Purpura Therapy Drugs Revenue and Market Share by Type (2014-2019)
10.2 Allergic Purpura Sales Growth and Price
10.2.1 Global Allergic Purpura Sales Growth (2014-2019)
10.2.2 Global Allergic Purpura Price (2014-2019)
10.3 Thrombocytopenic Purpura Sales Growth and Price
10.3.1 Global Thrombocytopenic Purpura Sales Growth (2014-2019)
10.3.2 Global Thrombocytopenic Purpura Price (2014-2019)
11 Global Purpura Therapy Drugs Market Segment by Application
11.1 Global Purpura Therapy Drugs Sales Market Share by Application (2014-2019)
11.2 Hospital Use Sales Growth (2014-2019)
11.3 Clinic Use Sales Growth (2014-2019)
11.4 Household Sales Growth (2014-2019)
11.5 Other Sales Growth (2014-2019)
12 Purpura Therapy Drugs Market Forecast (2019-2024)
12.1 Global Purpura Therapy Drugs Sales, Revenue and Growth Rate (2019-2024)
12.2 Purpura Therapy Drugs Market Forecast by Regions (2019-2024)
12.2.1 North America Purpura Therapy Drugs Market Forecast (2019-2024)
12.2.2 Europe Purpura Therapy Drugs Market Forecast (2019-2024)
12.2.3 Asia-Pacific Purpura Therapy Drugs Market Forecast (2019-2024)
12.2.4 South America Purpura Therapy Drugs Market Forecast (2019-2024)
12.2.5 Middle East and Africa Purpura Therapy Drugs Market Forecast (2019-2024)
12.3 Purpura Therapy Drugs Market Forecast by Type (2019-2024)
12.3.1 Global Purpura Therapy Drugs Sales Forecast by Type (2019-2024)
12.3.2 Global Purpura Therapy Drugs Market Share Forecast by Type (2019-2024)
12.4 Purpura Therapy Drugs Market Forecast by Application (2019-2024)
12.4.1 Global Purpura Therapy Drugs Sales Forecast by Application (2019-2024)
12.4.2 Global Purpura Therapy Drugs Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
Figure Purpura Therapy Drugs Picture
Table Product Specifications of Purpura Therapy Drugs
Figure Global Sales Market Share of Purpura Therapy Drugs by Types in 2018
Table Purpura Therapy Drugs Types for Major Manufacturers
Figure Allergic Purpura Picture
Figure Thrombocytopenic Purpura Picture
Figure Purpura Therapy Drugs Sales Market Share by Applications in 2018
Figure Hospital Use Picture
Figure Clinic Use Picture
Figure Household Picture
Figure Other Picture
Figure United States Purpura Therapy Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Purpura Therapy Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Purpura Therapy Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Purpura Therapy Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure France Purpura Therapy Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure UK Purpura Therapy Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Purpura Therapy Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Purpura Therapy Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure China Purpura Therapy Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Purpura Therapy Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Purpura Therapy Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure India Purpura Therapy Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Purpura Therapy Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Purpura Therapy Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Purpura Therapy Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Purpura Therapy Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Purpura Therapy Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Purpura Therapy Drugs Revenue (Value) and Growth Rate (2014-2024)
Table Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Company Purpura Therapy Drugs Type and Applications
Table Bristol-Myers Squibb Company Purpura Therapy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table Pfizer Inc Purpura Therapy Drugs Type and Applications
Table Pfizer Inc Purpura Therapy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table GlaxoSmithKline Plc Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline Plc Purpura Therapy Drugs Type and Applications
Table GlaxoSmithKline Plc Purpura Therapy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis AG Basic Information, Manufacturing Base and Competitors
Table Novartis AG Purpura Therapy Drugs Type and Applications
Table Novartis AG Purpura Therapy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Hovione Basic Information, Manufacturing Base and Competitors
Table Hovione Purpura Therapy Drugs Type and Applications
Table Hovione Purpura Therapy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Sanofi Winthrop Industrie S.A. Basic Information, Manufacturing Base and Competitors
Table Sanofi Winthrop Industrie S.A. Purpura Therapy Drugs Type and Applications
Table Sanofi Winthrop Industrie S.A. Purpura Therapy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Hoffman-L Roche Basic Information, Manufacturing Base and Competitors
Table Hoffman-L Roche Purpura Therapy Drugs Type and Applications
Table Hoffman-L Roche Purpura Therapy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Amgen Inc Basic Information, Manufacturing Base and Competitors
Table Amgen Inc Purpura Therapy Drugs Type and Applications
Table Amgen Inc Purpura Therapy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Grifols Biologicals Inc Basic Information, Manufacturing Base and Competitors
Table Grifols Biologicals Inc Purpura Therapy Drugs Type and Applications
Table Grifols Biologicals Inc Purpura Therapy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Ablynx NV Basic Information, Manufacturing Base and Competitors
Table Ablynx NV Purpura Therapy Drugs Type and Applications
Table Ablynx NV Purpura Therapy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Biogen Inc Basic Information, Manufacturing Base and Competitors
Table Biogen Inc Purpura Therapy Drugs Type and Applications
Table Biogen Inc Purpura Therapy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table KM Biologics Basic Information, Manufacturing Base and Competitors
Table KM Biologics Purpura Therapy Drugs Type and Applications
Table KM Biologics Purpura Therapy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Lee's Pharmaceutical Holdings Ltd Basic Information, Manufacturing Base and Competitors
Table Lee's Pharmaceutical Holdings Ltd Purpura Therapy Drugs Type and Applications
Table Lee's Pharmaceutical Holdings Ltd Purpura Therapy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Omeros Corp Basic Information, Manufacturing Base and Competitors
Table Omeros Corp Purpura Therapy Drugs Type and Applications
Table Omeros Corp Purpura Therapy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Shire Plc Basic Information, Manufacturing Base and Competitors
Table Shire Plc Purpura Therapy Drugs Type and Applications
Table Shire Plc Purpura Therapy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Roch Basic Information, Manufacturing Base and Competitors
Table Roch Purpura Therapy Drugs Type and Applications
Table Roch Purpura Therapy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Purpura Therapy Drugs Sales by Manufacturer (2017-2018)
Figure Global Purpura Therapy Drugs Sales Market Share by Manufacturer in 2017
Figure Global Purpura Therapy Drugs Sales Market Share by Manufacturer in 2018
Table Global Purpura Therapy Drugs Revenue by Manufacturer (2017-2018)
Figure Global Purpura Therapy Drugs Revenue Market Share by Manufacturer in 2017
Figure Global Purpura Therapy Drugs Revenue Market Share by Manufacturer in 2018
Figure Top 3 Purpura Therapy Drugs Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Purpura Therapy Drugs Manufacturer (Revenue) Market Share in 2018
Figure Global Purpura Therapy Drugs Sales and Growth Rate (2014-2019)
Figure Global Purpura Therapy Drugs Revenue and Growth Rate (2014-2019)
Table Global Purpura Therapy Drugs Sales by Regions (2014-2019)
Table Global Purpura Therapy Drugs Sales Market Share by Regions (2014-2019)
Table Global Purpura Therapy Drugs Revenue by Regions (2014-2019)
Figure Global Purpura Therapy Drugs Revenue Market Share by Regions in 2014
Figure Global Purpura Therapy Drugs Revenue Market Share by Regions in 2018
Figure North America Purpura Therapy Drugs Sales and Growth Rate (2014-2019)
Figure Europe Purpura Therapy Drugs Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Purpura Therapy Drugs Sales and Growth Rate (2014-2019)
Figure South America Purpura Therapy Drugs Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Purpura Therapy Drugs Sales and Growth Rate (2014-2019)
Figure North America Purpura Therapy Drugs Revenue and Growth Rate (2014-2019)
Table North America Purpura Therapy Drugs Sales by Countries (2014-2019)
Table North America Purpura Therapy Drugs Sales Market Share by Countries (2014-2019)
Figure North America Purpura Therapy Drugs Sales Market Share by Countries in 2014
Figure North America Purpura Therapy Drugs Sales Market Share by Countries in 2018
Table North America Purpura Therapy Drugs Revenue by Countries (2014-2019)
Table North America Purpura Therapy Drugs Revenue Market Share by Countries (2014-2019)
Figure North America Purpura Therapy Drugs Revenue Market Share by Countries in 2014
Figure North America Purpura Therapy Drugs Revenue Market Share by Countries in 2018
Figure United States Purpura Therapy Drugs Sales and Growth Rate (2014-2019)
Figure Canada Purpura Therapy Drugs Sales and Growth Rate (2014-2019)
Figure Mexico Purpura Therapy Drugs Sales and Growth Rate (2014-2019)
Figure Europe Purpura Therapy Drugs Revenue and Growth Rate (2014-2019)
Table Europe Purpura Therapy Drugs Sales by Countries (2014-2019)
Table Europe Purpura Therapy Drugs Sales Market Share by Countries (2014-2019)
Table Europe Purpura Therapy Drugs Revenue by Countries (2014-2019)
Figure Europe Purpura Therapy Drugs Revenue Market Share by Countries in 2017
Figure Europe Purpura Therapy Drugs Revenue Market Share by Countries in 2018
Figure Germany Purpura Therapy Drugs Sales and Growth Rate (2014-2019)
Figure UK Purpura Therapy Drugs Sales and Growth Rate (2014-2019)
Figure France Purpura Therapy Drugs Sales and Growth Rate (2014-2019)
Figure Russia Purpura Therapy Drugs Sales and Growth Rate (2014-2019)
Figure Italy Purpura Therapy Drugs Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Purpura Therapy Drugs Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Purpura Therapy Drugs Sales by Countries (2014-2019)
Table Asia-Pacific Purpura Therapy Drugs Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Purpura Therapy Drugs Sales Market Share by Countries 2018
Table Asia-Pacific Purpura Therapy Drugs Revenue by Countries (2014-2019)
Figure Asia-Pacific Purpura Therapy Drugs Revenue Market Share by Countries 2018
Figure China Purpura Therapy Drugs Sales and Growth Rate (2014-2019)
Figure Japan Purpura Therapy Drugs Sales and Growth Rate (2014-2019)
Figure Korea Purpura Therapy Drugs Sales and Growth Rate (2014-2019)
Figure India Purpura Therapy Drugs Sales and Growth Rate (2014-2019)
Figure Southeast Asia Purpura Therapy Drugs Sales and Growth Rate (2014-2019)
Figure South America Purpura Therapy Drugs Revenue and Growth Rate (2014-2019)
Table South America Purpura Therapy Drugs Sales by Countries (2014-2019)
Table South America Purpura Therapy Drugs Sales Market Share by Countries (2014-2019)
Figure South America Purpura Therapy Drugs Sales Market Share by Countries in 2018
Table South America Purpura Therapy Drugs Revenue by Countries (2014-2019)
Table South America Purpura Therapy Drugs Revenue Market Share by Countries (2014-2019)
Figure South America Purpura Therapy Drugs Revenue Market Share by Countries in 2018
Figure Brazil Purpura Therapy Drugs Sales and Growth Rate (2014-2019)
Figure Argentina Purpura Therapy Drugs Sales and Growth Rate (2014-2019)
Figure Colombia Purpura Therapy Drugs Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Purpura Therapy Drugs Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Purpura Therapy Drugs Sales by Countries (2014-2019)
Table Middle East and Africa Purpura Therapy Drugs Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Purpura Therapy Drugs Sales Market Share by Countries in 2018
Table Middle East and Africa Purpura Therapy Drugs Revenue by Countries (2014-2019)
Table Middle East and Africa Purpura Therapy Drugs Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Purpura Therapy Drugs Revenue Market Share by Countries in 2014
Figure Middle East and Africa Purpura Therapy Drugs Revenue Market Share by Countries in 2018
Figure Saudi Arabia Purpura Therapy Drugs Sales and Growth Rate (2014-2019)
Figure UAE Purpura Therapy Drugs Sales and Growth Rate (2014-2019)
Figure Egypt Purpura Therapy Drugs Sales and Growth Rate (2014-2019)
Figure Nigeria Purpura Therapy Drugs Sales and Growth Rate (2014-2019)
Figure South Africa Purpura Therapy Drugs Sales and Growth Rate (2014-2019)
Table Global Purpura Therapy Drugs Sales by Type (2014-2019)
Table Global Purpura Therapy Drugs Sales Share by Type (2014-2019)
Table Global Purpura Therapy Drugs Revenue by Type (2014-2019)
Table Global Purpura Therapy Drugs Revenue Share by Type (2014-2019)
Figure Global Allergic Purpura Sales Growth (2014-2019)
Figure Global Allergic Purpura Price (2014-2019)
Figure Global Thrombocytopenic Purpura Sales Growth (2014-2019)
Figure Global Thrombocytopenic Purpura Price (2014-2019)
Table Global Purpura Therapy Drugs Sales by Application (2014-2019)
Table Global Purpura Therapy Drugs Sales Share by Application (2014-2019)
Figure Global Clinic Use Sales Growth (2014-2019)
Figure Global Household Sales Growth (2014-2019)
Figure Global Other Sales Growth (2014-2019)
Figure Global Purpura Therapy Drugs Sales, Revenue and Growth Rate (2019-2024)
Table Global Purpura Therapy Drugs Sales Forecast by Regions (2019-2024)
Table Global Purpura Therapy Drugs Market Share Forecast by Regions (2019-2024)
Figure North America Sales Purpura Therapy Drugs Market Forecast (2019-2024)
Figure Europe Sales Purpura Therapy Drugs Market Forecast (2019-2024)
Figure Asia-Pacific Sales Purpura Therapy Drugs Market Forecast (2019-2024)
Figure South America Sales Purpura Therapy Drugs Market Forecast (2019-2024)
Figure Middle East and Africa Sales Purpura Therapy Drugs Market Forecast (2019-2024)
Table Global Purpura Therapy Drugs Sales Forecast by Type (2019-2024)
Table Global Purpura Therapy Drugs Market Share Forecast by Type (2019-2024)
Table Global Purpura Therapy Drugs Sales Forecast by Application (2019-2024)
Table Global Purpura Therapy Drugs Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
世界のがんホルモン療法薬市場予測（～2024年） Hormone Therapy, (also called hormonal therapy, hormone treatment, or endocrine therapy) is a cancer treatment that blocks or lowers the growth of cancer that uses hormones to grow. Doctors use it to treat some cancers such as breast and prostate cancer. Scope of the Report: The global Cancer Hormon…- 世界のアレルギー性鼻炎免疫療法市場予測（～2024年） Allergic rhinitis, sometimes referred to as hay fever, is an inflammatory disease that causes sneezing, itchy or watery eyes, itchy or runny nose and congestion. Scope of the Report: The global Allergic Rhinitis Immunotherapies market is valued at xx million USD in 2018 and is expected to reach xx m…
- 世界のイロプロスト薬市場予測（～2024年） Iloprost is a drug used to treat pulmonary arterial hypertension (PAH), scleroderma, Raynaud's phenomenon and other diseases in which the blood vessels are constricted and blood can't flow to the tissues. Scope of the Report: The worldwide market for Iloprost Drugs is expected to grow at a CAGR of …
- 世界のエポプロステノールナトリウム薬市場予測（～2024年） Epoprostenol sodium directly simulates prostaglandin receptors in arterial vascular smooth muscle, thereby causing vasodilatation. Scope of the Report: The worldwide market for Epoprostenol Sodium Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ …
- 世界の院内感染肺炎薬パイプライン分析市場予測（～2024年） Nosocomial or hospital acquired infections have created numerous complications for patients in hospitals throughout the world, as these infections are caused by multidrug resistant microorganisms, the recuperation of a patient is drastically reduced and accompanied by several comorbidities. Being mu…